

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.11836720 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.11836720 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.86460635 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.86460635 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.49113964 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.02142083 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.94773654 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.94773654 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.94773654 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.77747190 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.61480817 |
| 12 | cysteine metabolic process (GO:0006534) | 5.58979347 |
| 13 | lysine metabolic process (GO:0006553) | 5.44064781 |
| 14 | lysine catabolic process (GO:0006554) | 5.44064781 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.33544425 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.30847581 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.24046122 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.23201053 |
| 19 | drug transmembrane transport (GO:0006855) | 5.16190709 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.08219845 |
| 21 | urate metabolic process (GO:0046415) | 4.80492305 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.78862686 |
| 23 | aromatic amino acid family metabolic process (GO:0009072) | 4.77227779 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 4.75305624 |
| 25 | urea metabolic process (GO:0019627) | 4.72926477 |
| 26 | urea cycle (GO:0000050) | 4.72926477 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.69520685 |
| 28 | protein carboxylation (GO:0018214) | 4.69520685 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.64375242 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.64088535 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 4.56070135 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.54867090 |
| 33 | drug catabolic process (GO:0042737) | 4.52697489 |
| 34 | bile acid metabolic process (GO:0008206) | 4.45228625 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.44427508 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.41937249 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.39205579 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.34502661 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 4.33447380 |
| 40 | short-chain fatty acid metabolic process (GO:0046459) | 4.29568649 |
| 41 | drug transport (GO:0015893) | 4.26051175 |
| 42 | regulation of fibrinolysis (GO:0051917) | 4.24537907 |
| 43 | regulation of protein activation cascade (GO:2000257) | 4.24268816 |
| 44 | cellular amino acid catabolic process (GO:0009063) | 4.18982729 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.18907702 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 4.18730334 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.17113121 |
| 48 | valine metabolic process (GO:0006573) | 4.15208803 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.15043212 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.15043212 |
| 51 | glutamate metabolic process (GO:0006536) | 4.13841178 |
| 52 | negative regulation of granulocyte differentiation (GO:0030853) | 4.07832342 |
| 53 | benzene-containing compound metabolic process (GO:0042537) | 4.07641132 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.06142291 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.06142291 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 4.04937343 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.04770742 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 4.04683587 |
| 59 | amine catabolic process (GO:0009310) | 4.04683587 |
| 60 | cellular glucuronidation (GO:0052695) | 3.99961886 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.99261192 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.99261192 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.99261192 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 3.96546550 |
| 65 | regulation of complement activation (GO:0030449) | 3.96255814 |
| 66 | ketone body metabolic process (GO:1902224) | 3.96139314 |
| 67 | exogenous drug catabolic process (GO:0042738) | 3.93972566 |
| 68 | 2-oxoglutarate metabolic process (GO:0006103) | 3.93027437 |
| 69 | fatty acid beta-oxidation (GO:0006635) | 3.92758359 |
| 70 | phospholipid efflux (GO:0033700) | 3.91667736 |
| 71 | fatty acid oxidation (GO:0019395) | 3.84390349 |
| 72 | aspartate family amino acid catabolic process (GO:0009068) | 3.83115410 |
| 73 | regulation of extracellular matrix disassembly (GO:0010715) | 3.81071684 |
| 74 | ethanol oxidation (GO:0006069) | 3.80986599 |
| 75 | acetyl-CoA metabolic process (GO:0006084) | 3.80122108 |
| 76 | carboxylic acid catabolic process (GO:0046395) | 3.79634945 |
| 77 | organic acid catabolic process (GO:0016054) | 3.79634945 |
| 78 | carnitine metabolic process (GO:0009437) | 3.79411041 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.78845942 |
| 80 | coenzyme catabolic process (GO:0009109) | 3.77449963 |
| 81 | lipid oxidation (GO:0034440) | 3.77306534 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.76627000 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.74989266 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.70178925 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.68527541 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.66875871 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.66875871 |
| 88 | glycine metabolic process (GO:0006544) | 3.66662980 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.66397462 |
| 90 | fatty acid catabolic process (GO:0009062) | 3.65482007 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60332047 |
| 92 | cholesterol efflux (GO:0033344) | 3.54284255 |
| 93 | branched-chain amino acid metabolic process (GO:0009081) | 3.48999754 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.48850453 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 3.48178392 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.48160264 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46660084 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46660084 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.46561100 |
| 100 | sterol homeostasis (GO:0055092) | 3.44979033 |
| 101 | drug metabolic process (GO:0017144) | 3.38493261 |
| 102 | branched-chain amino acid catabolic process (GO:0009083) | 3.38221005 |
| 103 | response to mercury ion (GO:0046689) | 3.38193115 |
| 104 | mannose metabolic process (GO:0006013) | 3.37580850 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33698473 |
| 106 | regulation of tolerance induction (GO:0002643) | 3.25920829 |
| 107 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.24058991 |
| 108 | positive regulation of mast cell degranulation (GO:0043306) | 3.24058991 |
| 109 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.21743687 |
| 110 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.14130020 |
| 111 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.10090316 |
| 112 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06089659 |
| 113 | macroautophagy (GO:0016236) | 3.04591394 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97492548 |
| 115 | regulation of granulocyte differentiation (GO:0030852) | 2.96197442 |
| 116 | negative regulation of humoral immune response (GO:0002921) | 2.91893762 |
| 117 | regulation of sequestering of triglyceride (GO:0010889) | 2.90305097 |
| 118 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.86137306 |
| 119 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.86023875 |
| 120 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85128515 |
| 121 | regulation of T cell cytokine production (GO:0002724) | 2.84485142 |
| 122 | axoneme assembly (GO:0035082) | 2.84324425 |
| 123 | regulation of fatty acid oxidation (GO:0046320) | 2.78943676 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.68849127 |
| 125 | keratan sulfate catabolic process (GO:0042340) | 2.68590601 |
| 126 | regulation of execution phase of apoptosis (GO:1900117) | 2.65885158 |
| 127 | negative regulation of complement activation (GO:0045916) | 2.60911696 |
| 128 | ethanol metabolic process (GO:0006067) | 2.57561565 |
| 129 | fatty acid transmembrane transport (GO:1902001) | 2.57195775 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57096857 |
| 131 | norepinephrine metabolic process (GO:0042415) | 2.49140461 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.49018945 |
| 133 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.44564569 |
| 134 | white fat cell differentiation (GO:0050872) | 2.44397728 |
| 135 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.43094448 |
| 136 | carnitine transmembrane transport (GO:1902603) | 2.42968441 |
| 137 | glycogen catabolic process (GO:0005980) | 2.39511896 |
| 138 | cilium movement (GO:0003341) | 2.39353664 |
| 139 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.38999649 |
| 140 | carnitine transport (GO:0015879) | 2.38435962 |
| 141 | amino-acid betaine transport (GO:0015838) | 2.38435962 |
| 142 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38000746 |
| 143 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.36652427 |
| 144 | positive regulation of histone deacetylation (GO:0031065) | 2.36495636 |
| 145 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35910693 |
| 146 | triglyceride catabolic process (GO:0019433) | 2.35798064 |
| 147 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.33826361 |
| 148 | epithelial cilium movement (GO:0003351) | 2.30753285 |
| 149 | positive regulation of receptor recycling (GO:0001921) | 2.30721193 |
| 150 | lipoxygenase pathway (GO:0019372) | 2.30578847 |
| 151 | amyloid precursor protein catabolic process (GO:0042987) | 2.30466829 |
| 152 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.29820700 |
| 153 | peroxisome fission (GO:0016559) | 2.29536721 |
| 154 | response to epinephrine (GO:0071871) | 2.29255031 |
| 155 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.28873534 |
| 156 | carnitine shuttle (GO:0006853) | 2.28482947 |
| 157 | lytic vacuole organization (GO:0080171) | 2.26969695 |
| 158 | lysosome organization (GO:0007040) | 2.26969695 |
| 159 | eosinophil chemotaxis (GO:0048245) | 2.25304472 |
| 160 | response to water (GO:0009415) | 2.25122895 |
| 161 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.24946603 |
| 162 | endosome to melanosome transport (GO:0035646) | 2.24916955 |
| 163 | endosome to pigment granule transport (GO:0043485) | 2.24916955 |
| 164 | T cell apoptotic process (GO:0070231) | 2.24211229 |
| 165 | negative regulation of protein activation cascade (GO:2000258) | 2.23900946 |
| 166 | low-density lipoprotein particle clearance (GO:0034383) | 2.23464565 |
| 167 | fibril organization (GO:0097435) | 2.23398789 |
| 168 | face development (GO:0060324) | 2.21369656 |
| 169 | cellular polysaccharide catabolic process (GO:0044247) | 2.19925738 |
| 170 | positive regulation of granulocyte differentiation (GO:0030854) | 2.19027646 |
| 171 | peptide hormone processing (GO:0016486) | 2.18396363 |
| 172 | regulation of plasminogen activation (GO:0010755) | 2.18333288 |
| 173 | glucan catabolic process (GO:0009251) | 2.17728276 |
| 174 | regulation of mast cell activation (GO:0033003) | 2.17362616 |
| 175 | cellular response to epinephrine stimulus (GO:0071872) | 2.15473927 |
| 176 | intestinal cholesterol absorption (GO:0030299) | 2.14467216 |
| 177 | angiogenesis involved in wound healing (GO:0060055) | 2.14220626 |
| 178 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.13258273 |
| 179 | eosinophil migration (GO:0072677) | 2.12813507 |
| 180 | axonemal dynein complex assembly (GO:0070286) | 2.11301004 |
| 181 | lymphocyte apoptotic process (GO:0070227) | 2.11294343 |
| 182 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.11139450 |
| 183 | virion attachment to host cell (GO:0019062) | 2.10718295 |
| 184 | adhesion of symbiont to host cell (GO:0044650) | 2.10718295 |
| 185 | negative regulation of cell size (GO:0045792) | 2.10262847 |
| 186 | negative regulation of interleukin-8 production (GO:0032717) | 2.09684591 |
| 187 | extracellular negative regulation of signal transduction (GO:1900116) | 2.08604282 |
| 188 | extracellular regulation of signal transduction (GO:1900115) | 2.08604282 |
| 189 | adhesion of symbiont to host (GO:0044406) | 2.07362091 |
| 190 | xenobiotic catabolic process (GO:0042178) | 2.07337453 |
| 191 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.06062518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.89918352 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.84025894 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22459862 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.82024146 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.17054192 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71270009 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.19543538 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.95839222 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89236191 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.54763633 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38587858 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34445366 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06215010 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06090628 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9155350 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84931789 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82568835 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81211897 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71223909 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68193127 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56209925 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55029923 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53579326 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51578190 |
| 25 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49284544 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48431955 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47640208 |
| 28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42163070 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41590783 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39682113 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38333132 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37493362 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37090312 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36484173 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35801469 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30294002 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30109551 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27726645 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27551058 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26841311 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26298367 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25867327 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23793806 |
| 44 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23700695 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22726465 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22235345 |
| 47 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21799730 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21717460 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21527405 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20088063 |
| 51 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19723355 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19295032 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17149361 |
| 54 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16883537 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16348061 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15672315 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.14701481 |
| 58 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14581762 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13917344 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13580957 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12196935 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11215170 |
| 63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09091814 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06699611 |
| 65 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04318200 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04314081 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04099454 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01068132 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00093746 |
| 70 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99563820 |
| 71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99018851 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98864481 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98394915 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97281344 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97205407 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96502506 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96073730 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95646561 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94862822 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94500266 |
| 81 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94422317 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94383711 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 0.94152820 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.94044732 |
| 85 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93948786 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93585856 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93525870 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93476589 |
| 89 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.92995199 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91223968 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90974758 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90667435 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90030154 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89891835 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89864897 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89292372 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86758167 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85537092 |
| 99 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84645515 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84141524 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80659124 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80014037 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79296740 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77776306 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77653249 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77430556 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72158993 |
| 108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71225890 |
| 109 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70593268 |
| 110 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70593268 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69636691 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69237934 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69237934 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69033742 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68393160 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67915261 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66854178 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65905575 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64501831 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64257360 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63972094 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63442377 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62830632 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62669010 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62135957 |
| 126 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61349237 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61238375 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61201860 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.61174444 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60937694 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60506825 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60000258 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58343060 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57614636 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.57186485 |
| 136 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57017641 |
| 137 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55603211 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55500564 |
| 139 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.55375355 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55206391 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54460869 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.54362967 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53805999 |
| 144 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53729485 |
| 145 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.52932376 |
| 146 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52628256 |
| 147 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51365102 |
| 148 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50153817 |
| 149 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.50006408 |
| 150 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.49307386 |
| 151 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.48549121 |
| 152 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.48411471 |
| 153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47325158 |
| 154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46545377 |
| 155 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.46468247 |
| 156 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.45591175 |
| 157 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.45537695 |
| 158 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.45460157 |
| 159 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45433749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.98078798 |
| 2 | MP0005360_urolithiasis | 7.76714330 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.47257323 |
| 4 | MP0005365_abnormal_bile_salt | 5.43542672 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67203097 |
| 6 | MP0003252_abnormal_bile_duct | 3.76150332 |
| 7 | MP0003195_calcinosis | 3.64031256 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.36356477 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.26928353 |
| 10 | MP0005332_abnormal_amino_acid | 3.22558636 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.88513799 |
| 12 | MP0009840_abnormal_foam_cell | 2.84000485 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.82424702 |
| 14 | MP0003279_aneurysm | 2.81980881 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.45276870 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.44987631 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.33886711 |
| 18 | MP0005083_abnormal_biliary_tract | 2.33641855 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.33293265 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.29713343 |
| 21 | MP0009643_abnormal_urine_homeostasis | 2.08685736 |
| 22 | MP0000751_myopathy | 2.05326269 |
| 23 | MP0000609_abnormal_liver_physiology | 2.01620415 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.01282237 |
| 25 | MP0000003_abnormal_adipose_tissue | 2.01121818 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.91962065 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.88055186 |
| 28 | MP0002933_joint_inflammation | 1.80107892 |
| 29 | MP0001958_emphysema | 1.78804656 |
| 30 | MP0005330_cardiomyopathy | 1.78523331 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.74768833 |
| 32 | MP0004043_abnormal_pH_regulation | 1.66628768 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65246000 |
| 34 | MP0001764_abnormal_homeostasis | 1.62529754 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.56697709 |
| 36 | MP0005451_abnormal_body_composition | 1.48375942 |
| 37 | MP0009697_abnormal_copulation | 1.47590069 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.47566842 |
| 39 | MP0001542_abnormal_bone_strength | 1.37343758 |
| 40 | MP0004133_heterotaxia | 1.37209639 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.35601439 |
| 42 | MP0005171_absent_coat_pigmentation | 1.33786740 |
| 43 | MP0003186_abnormal_redox_activity | 1.33307649 |
| 44 | MP0003868_abnormal_feces_composition | 1.29574470 |
| 45 | MP0001756_abnormal_urination | 1.27393284 |
| 46 | MP0002127_abnormal_cardiovascular_syste | 1.27161092 |
| 47 | MP0001873_stomach_inflammation | 1.22334555 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.22330656 |
| 49 | MP0006054_spinal_hemorrhage | 1.20711793 |
| 50 | MP0001765_abnormal_ion_homeostasis | 1.20232096 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.19859076 |
| 52 | MP0005670_abnormal_white_adipose | 1.17368956 |
| 53 | MP0000749_muscle_degeneration | 1.13283800 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.13191476 |
| 55 | MP0002136_abnormal_kidney_physiology | 1.12917605 |
| 56 | MP0008775_abnormal_heart_ventricle | 1.12280547 |
| 57 | MP0003828_pulmonary_edema | 1.12263001 |
| 58 | MP0001881_abnormal_mammary_gland | 1.12118702 |
| 59 | MP0000598_abnormal_liver_morphology | 1.11348487 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.10364118 |
| 61 | MP0002132_abnormal_respiratory_system | 1.10245423 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.09936479 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.09791176 |
| 64 | MP0005647_abnormal_sex_gland | 1.07083610 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.05063332 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.04147474 |
| 67 | MP0006138_congestive_heart_failure | 1.03627773 |
| 68 | MP0000604_amyloidosis | 1.03252065 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.02540582 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.01164122 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.00825776 |
| 72 | MP0009764_decreased_sensitivity_to | 0.99800633 |
| 73 | MP0004087_abnormal_muscle_fiber | 0.99294147 |
| 74 | MP0002653_abnormal_ependyma_morphology | 0.97782563 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.96919980 |
| 76 | MP0005164_abnormal_response_to | 0.96075822 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.96074183 |
| 78 | MP0003011_delayed_dark_adaptation | 0.95488624 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.94667215 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.94153878 |
| 81 | MP0001661_extended_life_span | 0.93367153 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.93036180 |
| 83 | MP0008469_abnormal_protein_level | 0.91427953 |
| 84 | MP0005452_abnormal_adipose_tissue | 0.90912299 |
| 85 | MP0002419_abnormal_innate_immunity | 0.90472079 |
| 86 | MP0002405_respiratory_system_inflammati | 0.90389796 |
| 87 | MP0000343_altered_response_to | 0.89295656 |
| 88 | MP0009763_increased_sensitivity_to | 0.88595379 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.88232693 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.87963085 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.87840654 |
| 92 | MP0005535_abnormal_body_temperature | 0.86697022 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.86597862 |
| 94 | MP0005025_abnormal_response_to | 0.84623366 |
| 95 | MP0004130_abnormal_muscle_cell | 0.82810526 |
| 96 | MP0005334_abnormal_fat_pad | 0.82467407 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.81741148 |
| 98 | MP0004883_abnormal_blood_vessel | 0.80514145 |
| 99 | MP0002128_abnormal_blood_circulation | 0.80402872 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.80315484 |
| 101 | MP0002254_reproductive_system_inflammat | 0.80078577 |
| 102 | MP0005390_skeleton_phenotype | 0.79783688 |
| 103 | MP0001851_eye_inflammation | 0.79773154 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.78445456 |
| 105 | MP0004381_abnormal_hair_follicle | 0.77995124 |
| 106 | MP0004484_altered_response_of | 0.75359410 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.74607117 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.74318781 |
| 109 | MP0002971_abnormal_brown_adipose | 0.73901321 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.73495368 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.72492525 |
| 112 | MP0001544_abnormal_cardiovascular_syste | 0.72431946 |
| 113 | MP0005385_cardiovascular_system_phenoty | 0.72431946 |
| 114 | MP0000733_abnormal_muscle_development | 0.72098817 |
| 115 | MP0000858_altered_metastatic_potential | 0.71778487 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.71142421 |
| 117 | MP0002928_abnormal_bile_duct | 0.70713939 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.70581353 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.69515777 |
| 120 | MP0003690_abnormal_glial_cell | 0.69252656 |
| 121 | MP0005408_hypopigmentation | 0.68214220 |
| 122 | MP0003300_gastrointestinal_ulcer | 0.66022206 |
| 123 | MP0002168_other_aberrant_phenotype | 0.65264005 |
| 124 | MP0003329_amyloid_beta_deposits | 0.62993837 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.61552816 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.60694583 |
| 127 | MP0003953_abnormal_hormone_level | 0.59631539 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.57730499 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.54938488 |
| 130 | MP0003724_increased_susceptibility_to | 0.53217829 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.52818590 |
| 132 | MP0005266_abnormal_metabolism | 0.51923045 |
| 133 | MP0005448_abnormal_energy_balance | 0.50208014 |
| 134 | MP0005395_other_phenotype | 0.49883722 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.49286572 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.48834454 |
| 137 | MP0001944_abnormal_pancreas_morphology | 0.48059280 |
| 138 | MP0002896_abnormal_bone_mineralization | 0.46299434 |
| 139 | MP0004147_increased_porphyrin_level | 0.45460510 |
| 140 | MP0000538_abnormal_urinary_bladder | 0.44753790 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.44639845 |
| 142 | MP0003075_altered_response_to | 0.43981007 |
| 143 | MP0003172_abnormal_lysosome_physiology | 0.42933573 |
| 144 | MP0000249_abnormal_blood_vessel | 0.42530660 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.38629002 |
| 146 | MP0009672_abnormal_birth_weight | 0.37518234 |
| 147 | MP0009115_abnormal_fat_cell | 0.37413874 |
| 148 | MP0006082_CNS_inflammation | 0.37376988 |
| 149 | MP0008873_increased_physiological_sensi | 0.37238529 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.36854278 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.36544613 |
| 152 | MP0003436_decreased_susceptibility_to | 0.36024740 |
| 153 | MP0003959_abnormal_lean_body | 0.35138328 |
| 154 | MP0005166_decreased_susceptibility_to | 0.34665027 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.34525035 |
| 156 | MP0002970_abnormal_white_adipose | 0.31647457 |
| 157 | MP0002295_abnormal_pulmonary_circulatio | 0.31550746 |
| 158 | MP0000371_diluted_coat_color | 0.31200979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.46048924 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.83900133 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.75309839 |
| 4 | Xanthomatosis (HP:0000991) | 5.36015077 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.30556730 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.99594066 |
| 7 | J-shaped sella turcica (HP:0002680) | 4.76697007 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.75122370 |
| 9 | Complement deficiency (HP:0004431) | 4.64964740 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.59100941 |
| 11 | Ketosis (HP:0001946) | 4.58410883 |
| 12 | Hyperglycinuria (HP:0003108) | 4.53271240 |
| 13 | Hyperammonemia (HP:0001987) | 4.22977576 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.21948474 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.21948474 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.15202697 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.13738800 |
| 18 | Cervical subluxation (HP:0003308) | 4.12437226 |
| 19 | Hyperglycinemia (HP:0002154) | 4.09749786 |
| 20 | Ketoacidosis (HP:0001993) | 3.98504076 |
| 21 | Gout (HP:0001997) | 3.97683848 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.95690452 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.95690452 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.95690452 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.91524944 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.89259783 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.89259783 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83988834 |
| 29 | Joint hemorrhage (HP:0005261) | 3.83399587 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.82124098 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.71877112 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.71326893 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.69011541 |
| 34 | Hypolipoproteinemia (HP:0010981) | 3.56743250 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 3.54250138 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.45700824 |
| 37 | Nuclear cataract (HP:0100018) | 3.44189187 |
| 38 | Joint stiffness (HP:0001387) | 3.41989836 |
| 39 | Epidermoid cyst (HP:0200040) | 3.41343694 |
| 40 | Fat malabsorption (HP:0002630) | 3.40757257 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34896209 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.28602197 |
| 43 | Abnormality of complement system (HP:0005339) | 3.28457232 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.24097719 |
| 45 | Protrusio acetabuli (HP:0003179) | 3.17868436 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 3.17165299 |
| 47 | Proximal tubulopathy (HP:0000114) | 3.16544607 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 3.14689651 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13478415 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 3.12201472 |
| 51 | Delayed CNS myelination (HP:0002188) | 3.11545556 |
| 52 | Deformed sella turcica (HP:0002681) | 3.11416096 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.08720435 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 3.04901745 |
| 55 | Alkalosis (HP:0001948) | 2.94495861 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.90217839 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.88627265 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.87997401 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87997401 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.87663715 |
| 61 | Metabolic acidosis (HP:0001942) | 2.86862038 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.85659558 |
| 63 | Vascular calcification (HP:0004934) | 2.82269206 |
| 64 | Glucose intolerance (HP:0000833) | 2.75791252 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.74198863 |
| 66 | Aortic aneurysm (HP:0004942) | 2.73988645 |
| 67 | Glomerulonephritis (HP:0000099) | 2.70620790 |
| 68 | Increased purine levels (HP:0004368) | 2.68371788 |
| 69 | Hyperuricemia (HP:0002149) | 2.68371788 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.64909648 |
| 71 | Symptomatic seizures (HP:0011145) | 2.62132857 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.62052401 |
| 73 | Glycosuria (HP:0003076) | 2.62052401 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.61234635 |
| 75 | Late onset (HP:0003584) | 2.59836709 |
| 76 | Enlarged kidneys (HP:0000105) | 2.56476169 |
| 77 | Ovoid vertebral bodies (HP:0003300) | 2.55691272 |
| 78 | Lethargy (HP:0001254) | 2.53505323 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.51731386 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.51564189 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.50991188 |
| 82 | Malnutrition (HP:0004395) | 2.49561177 |
| 83 | Vascular tortuosity (HP:0004948) | 2.49480132 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48523763 |
| 85 | Rickets (HP:0002748) | 2.47891672 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.44859315 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.44859315 |
| 88 | Skin nodule (HP:0200036) | 2.44699789 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43822772 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43822772 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43822772 |
| 92 | Myocardial infarction (HP:0001658) | 2.43749378 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.43289336 |
| 94 | Steatorrhea (HP:0002570) | 2.42374776 |
| 95 | Increased circulating renin level (HP:0000848) | 2.41686852 |
| 96 | Aortic dissection (HP:0002647) | 2.40916985 |
| 97 | Rhinitis (HP:0012384) | 2.39908954 |
| 98 | Hypokalemic alkalosis (HP:0001949) | 2.38168632 |
| 99 | Irritability (HP:0000737) | 2.37938505 |
| 100 | Hypoplasia of the odontoid process (HP:0003311) | 2.36839802 |
| 101 | Arterial tortuosity (HP:0005116) | 2.36515895 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.35734713 |
| 103 | Vomiting (HP:0002013) | 2.34910430 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.31085412 |
| 105 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.30458582 |
| 106 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.30458582 |
| 107 | Pancreatitis (HP:0001733) | 2.28888062 |
| 108 | Protuberant abdomen (HP:0001538) | 2.26805166 |
| 109 | Decreased circulating renin level (HP:0003351) | 2.26463472 |
| 110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.25989315 |
| 111 | Aortic regurgitation (HP:0001659) | 2.25725117 |
| 112 | Albinism (HP:0001022) | 2.22742984 |
| 113 | Lymphangioma (HP:0100764) | 2.21502018 |
| 114 | Hematochezia (HP:0002573) | 2.20285082 |
| 115 | Mesangial abnormality (HP:0001966) | 2.19482940 |
| 116 | Hypophosphatemia (HP:0002148) | 2.17465548 |
| 117 | Abnormal ciliary motility (HP:0012262) | 2.17384265 |
| 118 | Abnormal urine output (HP:0012590) | 2.15905940 |
| 119 | Spastic diplegia (HP:0001264) | 2.14486880 |
| 120 | Metabolic alkalosis (HP:0200114) | 2.13254101 |
| 121 | Abnormality of the odontoid process (HP:0003310) | 2.12780822 |
| 122 | Neonatal onset (HP:0003623) | 2.11193494 |
| 123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.11153192 |
| 124 | Cerebral edema (HP:0002181) | 2.09534224 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 2.09232711 |
| 126 | Male infertility (HP:0003251) | 2.08240298 |
| 127 | Elevated alkaline phosphatase (HP:0003155) | 2.07702621 |
| 128 | Abnormality of dentin (HP:0010299) | 2.07622745 |
| 129 | Mitral stenosis (HP:0001718) | 2.07556032 |
| 130 | Spontaneous abortion (HP:0005268) | 2.06090001 |
| 131 | Premature rupture of membranes (HP:0001788) | 2.05715946 |
| 132 | Nephrolithiasis (HP:0000787) | 2.05081966 |
| 133 | Cupped ribs (HP:0000887) | 2.04914359 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 2.03710943 |
| 135 | Striae distensae (HP:0001065) | 2.02602151 |
| 136 | Polyuria (HP:0000103) | 2.02070807 |
| 137 | Exercise-induced myalgia (HP:0003738) | 2.00265330 |
| 138 | Pustule (HP:0200039) | 1.99129353 |
| 139 | Lipoatrophy (HP:0100578) | 1.97017027 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95483323 |
| 141 | Osteolytic defects of the hand bones (HP:0009699) | 1.95483323 |
| 142 | Hypochromic microcytic anemia (HP:0004840) | 1.95432569 |
| 143 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.95241464 |
| 144 | Abnormality of renal excretion (HP:0011036) | 1.94202799 |
| 145 | Abnormality of the sella turcica (HP:0002679) | 1.93607385 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.93488273 |
| 147 | Epistaxis (HP:0000421) | 1.91908376 |
| 148 | Hyperphosphaturia (HP:0003109) | 1.91806589 |
| 149 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91077336 |
| 150 | Round ear (HP:0100830) | 1.91003084 |
| 151 | Hypophosphatemic rickets (HP:0004912) | 1.90780424 |
| 152 | Brushfield spots (HP:0001088) | 1.90368790 |
| 153 | Increased CSF protein (HP:0002922) | 1.90241254 |
| 154 | Hyponatremia (HP:0002902) | 1.90153336 |
| 155 | Aneurysm (HP:0002617) | 1.89209609 |
| 156 | Hypertriglyceridemia (HP:0002155) | 1.88624782 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.88436569 |
| 158 | Gingival bleeding (HP:0000225) | 1.86673112 |
| 159 | Papilledema (HP:0001085) | 1.86373324 |
| 160 | Cholecystitis (HP:0001082) | 1.86354286 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.86354286 |
| 162 | Cholelithiasis (HP:0001081) | 1.84555151 |
| 163 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84521206 |
| 164 | Absent/shortened dynein arms (HP:0200106) | 1.84521206 |
| 165 | Dilatation of the ascending aorta (HP:0005111) | 1.79850393 |
| 166 | Atelectasis (HP:0100750) | 1.79840920 |
| 167 | Hyperkalemia (HP:0002153) | 1.77363491 |
| 168 | Broad face (HP:0000283) | 1.76333738 |
| 169 | Zonular cataract (HP:0010920) | 1.76263446 |
| 170 | Abnormality of the nasal mucosa (HP:0000433) | 1.76155381 |
| 171 | Flared iliac wings (HP:0002869) | 1.75861651 |
| 172 | Bone cyst (HP:0012062) | 1.75434124 |
| 173 | Increased connective tissue (HP:0009025) | 1.75334954 |
| 174 | Prolonged neonatal jaundice (HP:0006579) | 1.74932033 |
| 175 | Long toe (HP:0010511) | 1.74777405 |
| 176 | Nasal polyposis (HP:0100582) | 1.74671722 |
| 177 | Myositis (HP:0100614) | 1.74590297 |
| 178 | Ventricular tachycardia (HP:0004756) | 1.73553507 |
| 179 | Ventricular arrhythmia (HP:0004308) | 1.72816676 |
| 180 | Toxemia of pregnancy (HP:0100603) | 1.70190065 |
| 181 | Mitral regurgitation (HP:0001653) | 1.69130178 |
| 182 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.67705113 |
| 183 | Bronchiectasis (HP:0002110) | 1.67675020 |
| 184 | Aortic valve stenosis (HP:0001650) | 1.67202653 |
| 185 | Testicular atrophy (HP:0000029) | 1.66680414 |
| 186 | Stridor (HP:0010307) | 1.66206209 |
| 187 | Abnormal glucose tolerance (HP:0001952) | 1.65019404 |
| 188 | Upper limb amyotrophy (HP:0009129) | 1.63484244 |
| 189 | Distal upper limb amyotrophy (HP:0007149) | 1.63484244 |
| 190 | Neoplasm of the heart (HP:0100544) | 1.62578277 |
| 191 | Dilated cardiomyopathy (HP:0001644) | 1.61541092 |
| 192 | Absent frontal sinuses (HP:0002688) | 1.60697993 |
| 193 | Type 1 muscle fiber predominance (HP:0003803) | 1.60647884 |
| 194 | Spondylolisthesis (HP:0003302) | 1.59869732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.56006465 |
| 2 | ERN1 | 4.07051331 |
| 3 | WNK4 | 3.75386642 |
| 4 | INSRR | 3.58085798 |
| 5 | FGFR4 | 3.31350202 |
| 6 | SIK1 | 3.30177513 |
| 7 | WNK3 | 3.00548026 |
| 8 | TAOK3 | 2.91333397 |
| 9 | TNK2 | 2.43087888 |
| 10 | OXSR1 | 2.35084813 |
| 11 | PRKD2 | 2.28780832 |
| 12 | TRIB3 | 2.26512262 |
| 13 | PTK6 | 2.04747668 |
| 14 | PKN2 | 2.03034641 |
| 15 | LATS1 | 1.85715669 |
| 16 | TRPM7 | 1.84507276 |
| 17 | MST1R | 1.79250490 |
| 18 | EPHA2 | 1.77729460 |
| 19 | TGFBR2 | 1.75045775 |
| 20 | PIK3CA | 1.71647381 |
| 21 | MUSK | 1.69106183 |
| 22 | FRK | 1.64630723 |
| 23 | MAP4K2 | 1.61655481 |
| 24 | PIK3CG | 1.57008912 |
| 25 | MAPK15 | 1.54318239 |
| 26 | TYK2 | 1.53494775 |
| 27 | IRAK3 | 1.51391180 |
| 28 | MAPK11 | 1.42782614 |
| 29 | TAOK1 | 1.42499659 |
| 30 | EPHB1 | 1.33268034 |
| 31 | MAP3K3 | 1.32215238 |
| 32 | PTK2B | 1.29040761 |
| 33 | STK38L | 1.28951928 |
| 34 | STK38 | 1.24879201 |
| 35 | MAP2K4 | 1.22937147 |
| 36 | MAP2K3 | 1.21657461 |
| 37 | TTN | 1.18964261 |
| 38 | PHKG2 | 1.15868476 |
| 39 | PHKG1 | 1.15868476 |
| 40 | FLT3 | 1.14640944 |
| 41 | TBK1 | 1.12761589 |
| 42 | RIPK1 | 1.12579593 |
| 43 | JAK2 | 1.09998147 |
| 44 | ERBB2 | 1.09772547 |
| 45 | TIE1 | 1.08641086 |
| 46 | FES | 1.07401372 |
| 47 | STK39 | 1.07351935 |
| 48 | JAK3 | 1.06520704 |
| 49 | GRK7 | 1.05377198 |
| 50 | MYLK | 1.05151842 |
| 51 | JAK1 | 1.02454616 |
| 52 | ERBB4 | 1.02346482 |
| 53 | TRIM28 | 1.00526605 |
| 54 | ADRBK1 | 0.99920159 |
| 55 | MARK2 | 0.99584072 |
| 56 | MAP3K7 | 0.99249910 |
| 57 | CAMK1D | 0.98321904 |
| 58 | LRRK2 | 0.98315100 |
| 59 | PRKAA2 | 0.97687639 |
| 60 | FER | 0.97370387 |
| 61 | BTK | 0.95087732 |
| 62 | CDC42BPA | 0.93293042 |
| 63 | IKBKB | 0.92591105 |
| 64 | TESK1 | 0.90194924 |
| 65 | PRPF4B | 0.88197015 |
| 66 | MET | 0.87064889 |
| 67 | PDK3 | 0.85821899 |
| 68 | PDK4 | 0.85821899 |
| 69 | ABL2 | 0.84891304 |
| 70 | KDR | 0.84616948 |
| 71 | MAP3K13 | 0.83760420 |
| 72 | PTK2 | 0.82971387 |
| 73 | HIPK2 | 0.82960168 |
| 74 | NEK9 | 0.82598467 |
| 75 | DAPK2 | 0.81776487 |
| 76 | PRKD1 | 0.78473972 |
| 77 | MAP3K14 | 0.76073625 |
| 78 | GSK3A | 0.72634203 |
| 79 | MAPK4 | 0.72622990 |
| 80 | MAP2K2 | 0.71839054 |
| 81 | CAMK1G | 0.68678766 |
| 82 | SGK223 | 0.66187003 |
| 83 | SGK494 | 0.66187003 |
| 84 | PRKAA1 | 0.66180675 |
| 85 | SGK3 | 0.65398113 |
| 86 | PRKCE | 0.62786874 |
| 87 | ADRBK2 | 0.62763246 |
| 88 | VRK1 | 0.60273173 |
| 89 | PDK2 | 0.60148790 |
| 90 | GRK6 | 0.58439963 |
| 91 | ZAP70 | 0.58058871 |
| 92 | OBSCN | 0.57974477 |
| 93 | PRKACG | 0.57479698 |
| 94 | CSF1R | 0.55847482 |
| 95 | DYRK1B | 0.55583470 |
| 96 | ROCK1 | 0.55029785 |
| 97 | HCK | 0.54557356 |
| 98 | MAPK12 | 0.54495523 |
| 99 | STK10 | 0.54220522 |
| 100 | CSK | 0.54167522 |
| 101 | MAP3K6 | 0.54066622 |
| 102 | PDGFRB | 0.53325950 |
| 103 | PAK4 | 0.53268341 |
| 104 | IGF1R | 0.52104995 |
| 105 | DAPK3 | 0.51629967 |
| 106 | AKT3 | 0.51135551 |
| 107 | PINK1 | 0.50597676 |
| 108 | SGK2 | 0.50440482 |
| 109 | PRKCZ | 0.50389480 |
| 110 | BMX | 0.48281777 |
| 111 | GRK1 | 0.47828780 |
| 112 | CAMK1 | 0.47816183 |
| 113 | LCK | 0.47746489 |
| 114 | CDK6 | 0.46408300 |
| 115 | TEC | 0.45710684 |
| 116 | CAMK2D | 0.45589013 |
| 117 | MAP3K10 | 0.45249999 |
| 118 | MAP3K12 | 0.44796623 |
| 119 | ITK | 0.43734271 |
| 120 | GRK5 | 0.43721333 |
| 121 | CAMK4 | 0.43219642 |
| 122 | EPHA3 | 0.42971014 |
| 123 | STK3 | 0.42017405 |
| 124 | SYK | 0.41707576 |
| 125 | LYN | 0.41595672 |
| 126 | MAP4K1 | 0.41118603 |
| 127 | MAPK3 | 0.40655020 |
| 128 | PDPK1 | 0.40580997 |
| 129 | RPS6KB2 | 0.40467616 |
| 130 | MAPKAPK3 | 0.39834561 |
| 131 | MAP3K5 | 0.38560627 |
| 132 | PDK1 | 0.38358342 |
| 133 | MAPK7 | 0.37039748 |
| 134 | RET | 0.36093318 |
| 135 | MAP2K6 | 0.35286558 |
| 136 | IKBKE | 0.32708924 |
| 137 | CHUK | 0.31169735 |
| 138 | NUAK1 | 0.30801729 |
| 139 | EGFR | 0.29640253 |
| 140 | MAP3K2 | 0.28251863 |
| 141 | FGFR2 | 0.27340084 |
| 142 | WNK1 | 0.26642193 |
| 143 | MTOR | 0.25416628 |
| 144 | PAK3 | 0.25383623 |
| 145 | KIT | 0.25112337 |
| 146 | MAP3K11 | 0.24922273 |
| 147 | PRKCQ | 0.24212871 |
| 148 | PAK2 | 0.24053913 |
| 149 | BLK | 0.23998600 |
| 150 | PRKCA | 0.23441090 |
| 151 | RPS6KA2 | 0.23438943 |
| 152 | PRKCH | 0.21491446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.79731317 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44107958 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.93365368 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86449345 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.75523657 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75509410 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74986132 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67454327 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.60853083 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58857847 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55939704 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50381740 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.42011508 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35263689 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31588524 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31182735 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.27158895 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11446629 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98644087 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92048991 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.91382632 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91198331 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87633258 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82721733 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82610287 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82151259 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78808773 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69768954 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67142523 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66681107 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63592434 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62286403 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61209723 |
| 34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.58174244 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.55808078 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55347632 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.51379009 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47702156 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47075298 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45715234 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44847374 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41541447 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40842976 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39338461 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38982597 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35512907 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32604712 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.32295093 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.31947000 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26604061 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26348847 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25021839 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.24960067 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24395094 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23716173 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23314645 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 1.15601238 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14958412 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12379941 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 1.11824712 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11237213 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10947420 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10838486 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08877536 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06447949 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05043437 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04484116 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03847844 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95698408 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92925890 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.92133975 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88715130 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85557207 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83681906 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83349884 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80934478 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80218131 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80153951 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79758112 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77176591 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76411536 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74518691 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73010338 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71676374 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70490869 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70216436 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70027063 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69124837 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67026100 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66441236 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63879892 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.63844644 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63419705 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61780752 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57501453 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56796073 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56009346 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54776502 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52978533 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50908218 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.50487953 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50300442 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50161167 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50136010 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49298978 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47137866 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45944018 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44628684 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44336444 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44113425 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43577355 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41913882 |
| 113 | Salivary secretion_Homo sapiens_hsa04970 | 0.41237181 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41193792 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.41096587 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39987726 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39294756 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38445869 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38188921 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.37312374 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36952319 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.35772136 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35267847 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31341521 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26545293 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23739422 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22819494 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.21086903 |
| 129 | Lysosome_Homo sapiens_hsa04142 | 0.16366608 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14764932 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.14704097 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.14010356 |
| 133 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11783803 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06183768 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05405337 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04259531 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04235773 |
| 138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04211866 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04114297 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02839172 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01105629 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | -0.1556337 |
| 143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1397316 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1124851 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1047677 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1046742 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0813782 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0265992 |
| 149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0239300 |
| 150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0238178 |
| 151 | Protein export_Homo sapiens_hsa03060 | -0.0178588 |

